Mariner, LLC Becton Dickinson & CO Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Mariner, LLC holds 40,716 shares of BDX stock, worth $9.17 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

40,716

Previous 40,235 1.2%

Holding current value

$9.17 Million

Previous $9.4 Million 4.39%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$221.47 - $242.41 $106,527 - $116,599	481 Added 1.2%	40,716 $9.82 Million
Q2 2024 Aug 13, 2024	SELL	$225.07 - $246.17 $885,875 - $968,925	-3,936 Reduced 8.91%	40,235 $9.4 Million
Q1 2024 May 15, 2024	SELL	$233.45 - $247.73 $70,735 - $75,062	-303 Reduced 0.68%	44,171 $10.9 Million
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $155,833 - $179,311	-671 Reduced 1.49%	44,474 $10.8 Million
Q3 2023 Nov 13, 2023	BUY	$254.9 - $283.59 $381,585 - $424,534	1,497 Added 3.43%	45,145 $11.7 Million
Q2 2023 Aug 11, 2023	BUY	$238.39 - $265.32 $105,129 - $117,006	441 Added 1.02%	43,648 $11.5 Million
Q1 2023 May 12, 2023	BUY	$229.71 - $259.35 $651,457 - $735,516	2,836 Added 7.02%	43,207 $10.7 Million
Q4 2022 Feb 14, 2023	SELL	$218.29 - $256.91 $826,882 - $973,175	-3,788 Reduced 8.58%	40,371 $10.3 Million
Q3 2022 Nov 10, 2022	BUY	$51.03 - $264.23 $171,001 - $885,434	3,351 Added 8.21%	44,159 $9.84 Million
Q2 2022 Aug 15, 2022	SELL	$234.74 - $275.42 $2.9 Million - $3.4 Million	-12,342 Reduced 23.22%	40,808 $10.1 Million
Q1 2022 May 13, 2022	SELL	$243.64 - $270.48 $14.5 Million - $16.1 Million	-59,456 Reduced 52.8%	53,150 $14.1 Million
Q4 2021 Feb 14, 2022	BUY	$230.08 - $250.94 $988,883 - $1.08 Million	4,298 Added 3.97%	112,606 $28.3 Million
Q3 2021 Nov 15, 2021	BUY	$232.72 - $256.47 $1.45 Million - $1.59 Million	6,216 Added 6.09%	108,308 $26.6 Million
Q2 2021 Aug 24, 2021	BUY	$232.65 - $254.58 $1.09 Million - $1.19 Million	4,673 Added 4.8%	102,092 $24.8 Million
Q1 2021 May 07, 2021	BUY	$232.09 - $256.88 $1.47 Million - $1.63 Million	6,336 Added 6.96%	97,419 $23.7 Million
Q4 2020 Feb 16, 2021	BUY	$221.92 - $245.94 $797,802 - $884,154	3,595 Added 4.11%	91,083 $22.8 Million
Q3 2020 Nov 13, 2020	SELL	$215.77 - $276.76 $19.4 Million - $24.9 Million	-89,928 Reduced 50.69%	87,488 $20.4 Million
Q2 2020 Aug 14, 2020	BUY	$219.9 - $263.41 $1.05 Million - $1.25 Million	4,758 Added 2.76%	177,416 $42.5 Million
Q1 2020 May 14, 2020	BUY	$195.69 - $279.01 $1.1 Million - $1.57 Million	5,632 Added 3.37%	172,658 $39.7 Million
Q4 2019 Feb 13, 2020	SELL	$236.45 - $266.82 $7.92 Million - $8.94 Million	-33,508 Reduced 16.71%	167,026 $45.4 Million
Q3 2019 Nov 13, 2019	BUY	$230.58 - $256.08 $1.15 Million - $1.28 Million	4,993 Added 2.55%	200,534 $50.7 Million
Q2 2019 Aug 14, 2019	SELL	$217.4 - $246.08 $1.66 Million - $1.87 Million	-7,613 Reduced 3.75%	195,541 $49.3 Million
Q1 2019 May 15, 2019	BUY	$206.05 - $248.17 $9.99 Million - $12 Million	48,464 Added 31.33%	203,154 $39.7 Million
Q4 2018 Feb 13, 2019	BUY	$204.73 - $257.93 $27.7 Million - $34.9 Million	135,401 Added 701.96%	154,690 $34.9 Million
Q3 2018 Nov 14, 2018	SELL	$233.07 - $256.0 $6.54 Million - $7.18 Million	-28,042 Reduced 59.25%	19,289 $5.04 Million
Q2 2018 Aug 14, 2018	BUY	$208.1 - $233.85 $8.81 Million - $9.9 Million	42,339 Added 848.14%	47,331 $11.3 Million
Q1 2018 May 15, 2018	BUY	$205.46 - $240.27 $532,963 - $623,260	2,594 Added 108.17%	4,992 $1.08 Million
Q4 2017 Feb 09, 2018	BUY	$189.0 - $222.64 $453,222 - $533,890	2,398	2,398 $513,000

Others Institutions Holding BDX

# of Institutions

1,734

Shares Held

251M

Call Options Held

578K

Put Options Held

765K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account